Search results
Results from the WOW.Com Content Network
The New England Journal of Medicine (NEJM) is a weekly medical journal published by the Massachusetts Medical Society. Founded in 1812, the journal is among the most prestigious peer-reviewed medical journals. [1] Its 2023 impact factor was 96.2, ranking it 2nd out of 168 journals in the category "Medicine, General & Internal". [2]
Replika is a generative AI chatbot app released in November 2017. [1] The chatbot is trained by having the user answer a series of questions to create a specific neural network. [2] The chatbot operates on a freemium pricing strategy, with roughly 25% of its user base paying an annual subscription fee. [1]
Generative AI features have been integrated into a variety of existing commercially available products such as Microsoft Office (Microsoft Copilot), [85] Google Photos, [86] and the Adobe Suite (Adobe Firefly). [87] Many generative AI models are also available as open-source software, including Stable Diffusion and the LLaMA [88] language model.
Surgisphere provided dubious data used for studies of COVID-19 that were published in The Lancet [19] and The New England Journal of Medicine (NEJM) in May 2020. [ 20 ] [ 21 ] The Lancet study claimed that the dataset of hospital records showed that patients taking hydroxychloroquine were more likely to die in hospital, and prompted the World ...
Artificial intelligence in healthcare is the application of artificial intelligence (AI) to analyze and understand complex medical and healthcare data. In some cases, it can exceed or augment human capabilities by providing better or faster ways to diagnose, treat, or prevent disease.
Mustafa Suleyman CBE (born August 1984 [1]) is a British artificial intelligence (AI) entrepreneur. He is the CEO of Microsoft AI, and the co-founder and former head of applied AI at DeepMind, an AI company acquired by Google. [2] [3] After leaving DeepMind, he co-founded Inflection AI, a machine learning and generative AI company, in 2022. [4] [5]
HPTN 052 is the name of a clinical trial conducted in nine countries which examined whether starting people living with HIV on antiretroviral therapy (ART) can reduce the chance that they will pass HIV on to their sexual partners who do not have HIV. [1]
NEJM Journal Watch is a series of topic-specific newsletters written for physicians and other health professionals. It is published by the Massachusetts Medical Society and is a sibling publication to the New England Journal of Medicine. NEJM Journal Watch distributes its products via print, e-mail, and its website.